| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, …
Over the last 12 months, insiders at Nexalin Technology, Inc. have bought $0 and sold $0 worth of Nexalin Technology, Inc. stock.
On average, over the past 5 years, insiders at Nexalin Technology, Inc. have bought $20,437 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 6,000 shares for transaction amount of $13,200 was made by Shelton Carolyn Hamby (Sr. VP ‑ Quality, Regulatory) on 2025‑03‑12.
| 2025-03-12 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | 6,000 0.0441% | $2.20 | $13,200 | -55.56% | ||
| 2025-02-04 | Owens David | Chief Medical Officer | 2,000 0.0154% | $3.04 | $6,080 | -63.99% | ||
| 2025-02-04 | Owens David | Chief Medical Officer | 1,000 0.0076% | $2.98 | $2,980 | -63.99% | ||
| 2025-01-28 | Owens David | Chief Medical Officer | 1,500 0.0126% | $2.70 | $4,050 | -54.47% | ||
| 2025-01-23 | Owens David | Chief Medical Officer | 1,000 0.008% | $2.70 | $2,700 | -54.23% | ||
| 2025-01-13 | Owens David | Chief Medical Officer | 2,000 0.0156% | $2.50 | $5,000 | -51.79% | ||
| 2024-10-28 | Owens David | Chief Medical Officer | 500 0.0058% | $2.19 | $1,095 | -23.41% | ||
| 2024-08-13 | Owens David | Chief Medical Officer | 1,000 0.0097% | $0.95 | $950 | +80.21% | ||
| 2024-06-28 | Owens David | Chief Medical Officer | 1,000 0.0084% | $1.75 | $1,750 | +2.37% | ||
| 2024-06-18 | Owens David | Chief Medical Officer | 1,619 0.0056% | $0.71 | $1,149 | +69.23% | ||
| 2024-06-10 | Owens David | Chief Medical Officer | 3,000 0.0093% | $0.64 | $1,920 | +166.67% |
| Owens David | Chief Medical Officer | 154793 21.0973% | $238,381.22 | 10 | 0 | +0.66% |
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | 30000 4.0888% | $46,200.00 | 1 | 0 | <0.0001% |
$9,837,727 | 35 | 7.68% | $94.71M | |
$1,105,104 | 34 | -11.40% | $311.25M | |
$20,867,362 | 27 | -3.90% | $467.11M | |
$58,749,198 | 24 | 16.21% | $100.45M | |
$842,771 | 15 | 6.44% | $214.28M |
| Increased Positions | 15 | +83.33% | 747,821 | +105.93% |
| Decreased Positions | 7 | -38.89% | 220,121 | -31.18% |
| New Positions | 5 | New | 586,017 | New |
| Sold Out Positions | 6 | Sold Out | 176,497 | Sold Out |
| Total Postitions | 26 | +44.44% | 1M | +74.75% |
| Vanguard Group Inc | $103.00 | 0.93% | 176,582 | +16,704 | +10.45% | 2025-09-30 |
| Myda Advisors Llc | $87.00 | 0.79% | 150,000 | -650,000 | -81.25% | 2025-09-30 |
| Geode Capital Management, Llc | $71.00 | 0.64% | 121,820 | +5,454 | +4.69% | 2025-09-30 |
| Susquehanna International Group, Llp | $36.00 | 0.33% | 62,498 | +62,498 | New | 2025-09-30 |
| Renaissance Technologies Llc | $32.00 | 0.29% | 55,700 | +9,356 | +20.19% | 2025-09-30 |
| State Street Corp | $19.00 | 0.17% | 32,300 | 0 | 0% | 2025-09-30 |
| Jane Street Group, Llc | $17.00 | 0.16% | 29,534 | +29,534 | New | 2025-09-30 |
| Northern Trust Corp | $14.00 | 0.13% | 24,100 | 0 | 0% | 2025-09-30 |
| Xtx Topco Ltd | $7.00 | 0.06% | 11,909 | -10,235 | -46.22% | 2025-09-30 |
| Atria Wealth Solutions, Inc. | $6.00 | 0.05% | 10,347 | 0 | 0% | 2025-06-30 |